Literature DB >> 15466387

Role of CCR4 ligands, CCL17 and CCL22, during Schistosoma mansoni egg-induced pulmonary granuloma formation in mice.

Claudia Jakubzick1, Haitao Wen, Akihiro Matsukawa, Maya Keller, Steven L Kunkel, Cory M Hogaboam.   

Abstract

Controversy persists pertaining to the role of CCR4 ligands, namely CCL17 (or thymus and activation regulated chemokine; TARC) and CCL22 (or macrophage-derived chemokine; MDC), in Th2-type cytokine-dominated responses in the lung. Accordingly, the present study addressed the relative role of each of these CC chemokines during an evolving pulmonary granulomatous response elicited by the intrapulmonary embolization of live Schistosoma mansoni eggs into S. mansoni-sensitized mice. CCL22 protein expression peaked at day 4, but CCL17 levels were not increased significantly at any time after egg challenge. CCR4 transcript and protein expression were highest at day 8 after egg embolization and CCR4 protein was prominently expressed in macrophages surrounding S. mansoni eggs. Systemic immunoneutralization of CCL22 from the time of egg injection into S. mansoni-sensitized mice for 8 days significantly decreased CCR4 protein expression, the eosinophil content, the overall size of the egg granuloma, and its hydroxyproline content. Whole lung levels of interferon-gamma were also significantly increased at day 8 in anti-CCL22-treated mice. The systemic immunoneutralization of CCL17 had a lesser effect on all of the granuloma parameters listed above, but this antibody treatment significantly decreased granuloma hydroxyproline content to a greater extent than the anti-CCL22 antibody treatment. In addition, the immunoneutralization of CCL17 significantly increased whole lung levels of interleukin (IL)-4, IL-5, IL-13, transforming growth factor-beta, IL-12, and tumor necrosis factor-alpha at day 8 after egg infusion. Thus, these studies demonstrate a major role for CCL22 and a lesser role for CCL17 during an evolving S. mansoni egg granuloma in the lung.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15466387      PMCID: PMC1618636          DOI: 10.1016/S0002-9440(10)63381-0

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  73 in total

1.  Th2 cells are required for the Schistosoma mansoni egg-induced granulomatous response.

Authors:  M H Kaplan; J R Whitfield; D L Boros; M J Grusby
Journal:  J Immunol       Date:  1998-02-15       Impact factor: 5.422

2.  The granulomatous response in murine Schistosomiasis mansoni does not switch to Th1 in IL-4-deficient C57BL/6 mice.

Authors:  A Metwali; D Elliott; A M Blum; J Li; M Sandor; R Lynch; N Noben-Trauth; J V Weinstock
Journal:  J Immunol       Date:  1996-11-15       Impact factor: 5.422

Review 3.  Cell-to-cell and cell-to-matrix interactions mediate chemokine expression: an important component of the inflammatory lesion.

Authors:  R E Smith; C M Hogaboam; R M Strieter; N W Lukacs; S L Kunkel
Journal:  J Leukoc Biol       Date:  1997-11       Impact factor: 4.962

4.  The T cell-directed CC chemokine TARC is a highly specific biological ligand for CC chemokine receptor 4.

Authors:  T Imai; M Baba; M Nishimura; M Kakizaki; S Takagi; O Yoshie
Journal:  J Biol Chem       Date:  1997-06-06       Impact factor: 5.157

Review 5.  Cytokine regulation of schistosome-induced granuloma and fibrosis.

Authors:  S M Wahl; M Frazier-Jessen; W W Jin; J B Kopp; A Sher; A W Cheever
Journal:  Kidney Int       Date:  1997-05       Impact factor: 10.612

6.  Macrophage-derived chemokine is a functional ligand for the CC chemokine receptor 4.

Authors:  T Imai; D Chantry; C J Raport; C L Wood; M Nishimura; R Godiska; O Yoshie; P W Gray
Journal:  J Biol Chem       Date:  1998-01-16       Impact factor: 5.157

7.  Monocyte chemotactic protein expression during schistosome egg granuloma formation. Sequence of production, localization, contribution, and regulation.

Authors:  S W Chensue; K S Warmington; N W Lukacs; P M Lincoln; M D Burdick; R M Strieter; S L Kunkel
Journal:  Am J Pathol       Date:  1995-01       Impact factor: 4.307

8.  An IL-12-based vaccination method for preventing fibrosis induced by schistosome infection.

Authors:  T A Wynn; A W Cheever; D Jankovic; R W Poindexter; P Caspar; F A Lewis; A Sher
Journal:  Nature       Date:  1995-08-17       Impact factor: 49.962

9.  Recombinant IL-10 and IL-10/Fc treatment down-regulate egg antigen-specific delayed hypersensitivity reactions and egg granuloma formation in schistosomiasis.

Authors:  P O Flores-Villanueva; X X Zheng; T B Strom; M J Stadecker
Journal:  J Immunol       Date:  1996-05-01       Impact factor: 5.422

10.  Human macrophage-derived chemokine (MDC), a novel chemoattractant for monocytes, monocyte-derived dendritic cells, and natural killer cells.

Authors:  R Godiska; D Chantry; C J Raport; S Sozzani; P Allavena; D Leviten; A Mantovani; P W Gray
Journal:  J Exp Med       Date:  1997-05-05       Impact factor: 14.307

View more
  33 in total

Review 1.  Infectious disease, the innate immune response, and fibrosis.

Authors:  Alessia Meneghin; Cory M Hogaboam
Journal:  J Clin Invest       Date:  2007-03       Impact factor: 14.808

2.  Severe sepsis exacerbates cell-mediated immunity in the lung due to an altered dendritic cell cytokine profile.

Authors:  Haitao Wen; Cory M Hogaboam; Jack Gauldie; Steven L Kunkel
Journal:  Am J Pathol       Date:  2006-06       Impact factor: 4.307

3.  Echinococcus multilocularis metacestodes modulate cellular cytokine and chemokine release by peripheral blood mononuclear cells in alveolar echinococcosis patients.

Authors:  M P Hübner; B J Manfras; M C Margos; D Eiffler; W H Hoffmann; H Schulz-Key; P Kern; P T Soboslay
Journal:  Clin Exp Immunol       Date:  2006-08       Impact factor: 4.330

4.  Intrapulmonary, adenovirus-mediated overexpression of KARAP/DAP12 enhances fungal clearance during invasive aspergillosis.

Authors:  Kristin J Carpenter; Karen F Buckland; Zhou Xing; Cory M Hogaboam
Journal:  Infect Immun       Date:  2005-12       Impact factor: 3.441

5.  IL-4/CCL22/CCR4 axis controls regulatory T-cell migration that suppresses inflammatory bone loss in murine experimental periodontitis.

Authors:  Ana Claudia Araujo-Pires; Andreia Espindola Vieira; Carolina Favaro Francisconi; Claudia Cristina Biguetti; Andrew Glowacki; Sayuri Yoshizawa; Ana Paula Campanelli; Ana Paula Favaro Trombone; Charles S Sfeir; Steven R Little; Gustavo Pompermaier Garlet
Journal:  J Bone Miner Res       Date:  2015-03       Impact factor: 6.741

6.  CC chemokine receptor 4 contributes to innate NK and chronic stage T helper cell recall responses during Mycobacterium bovis infection.

Authors:  Valerie R Stolberg; Bo-Chin Chiu; Brian M Schmidt; Steven L Kunkel; Matyas Sandor; Stephen W Chensue
Journal:  Am J Pathol       Date:  2010-12-23       Impact factor: 4.307

7.  CCR4 contributes to the pathogenesis of experimental autoimmune encephalomyelitis by regulating inflammatory macrophage function.

Authors:  Eileen A Forde; Rukiye-Nazan E Dogan; William J Karpus
Journal:  J Neuroimmunol       Date:  2011-05-14       Impact factor: 3.478

Review 8.  Chemokines shape the immune responses to tuberculosis.

Authors:  Samantha R Slight; Shabaana A Khader
Journal:  Cytokine Growth Factor Rev       Date:  2012-11-16       Impact factor: 7.638

9.  Suppressive effect on MDC and IP-10 expression in monocytes by endocrine disruptor chemicals.

Authors:  Ching-Hui Yeh; Hsaing-Chi Wu; Thai-Hung Kuo; Chang-Hung Kuo; San-Nan Yang; Wei-Li Wang; Huan-Nan Chen; Wan-Ju Wei; Chih-Hsing Hung
Journal:  Inflammation       Date:  2010-02       Impact factor: 4.092

10.  Therapeutic targeting of CC ligand 21 or CC chemokine receptor 7 abrogates pulmonary fibrosis induced by the adoptive transfer of human pulmonary fibroblasts to immunodeficient mice.

Authors:  Elizabeth M Pierce; Kristin Carpenter; Claudia Jakubzick; Steven L Kunkel; Kevin R Flaherty; Fernando J Martinez; Cory M Hogaboam
Journal:  Am J Pathol       Date:  2007-04       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.